SNN or ESLOY: Which Is the Better Value Stock Right Now?

Core Insights - The article compares two stocks in the Medical - Products sector: Smith & Nephew (SNN) and EssilorLuxottica Unsponsored ADR (ESLOY) to determine which is more attractive to value investors [1] Valuation Metrics - Smith & Nephew has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while EssilorLuxottica has a Zacks Rank of 3 (Hold) [3] - SNN has a forward P/E ratio of 15.83, significantly lower than ESLOY's forward P/E of 35.31, suggesting SNN may be undervalued [5] - The PEG ratio for SNN is 0.96, while ESLOY's PEG ratio is 4.52, indicating SNN's expected earnings growth is more favorable [5] - SNN's P/B ratio is 2.58 compared to ESLOY's P/B of 3.01, further supporting SNN's valuation attractiveness [6] - SNN has a Value grade of A, while ESLOY has a Value grade of D, highlighting SNN's superior valuation metrics [6]